O s t e o m y e l i t i s
🦠  O s t e o m y e l i t i s :  T h e  B a s i c s
Ost eom y elitis :  An inf ection of the bone . This c an range fr om a loc aliz ed  
inf ection t o a se v er e, syst emic illness. Underst anding the dif f er ent t ypes is  
crucial.
A cut e Ost eom y elitis :  Inf ection lasting da ys t o w eeks . Charact er iz ed b y rapid  
onset of sympt oms.
Chr onic Ost eom y elitis :  Inf ection lasting months t o y ears . Of t en in v ol v es  
r ecur r ent episodes and the f or mation of  sequestr a  ( de ad bone fragment s).
Sequestr a :  Pieces of necr otic bone that separ at e fr om viable bone . These ar e  
a hallmar k of chr onic ost eom y elitis and impede he aling. Their pr esence of t en  
necessit at es sur gic al r emo v al.
Sinus T r act :  A pathognomonic ( char act er istic ) f eatur e of ost eom y elitis . I t's an  
abnor mal p assage le ading fr om a deep inf ection t o the skin sur f ace, of t en  
draining pus.
In v olucrum :  Ne w bone f or mation sur r ounding the ar ea of inf ection . The bod y's  
at t empt t o wall of f the inf ection.
P er iost e al Seeding :  Spr ead of inf ection fr om the bone t o the per iost eum ( out er  
co v er ing of the bone ) . This c an le ad t o fur ther inflammation and bone  
destruction.
Clo ac ae :  Mul tiple dr aining passages that can f or m in chr onic ost eom y elitis .  
These ar e of t en int er connect ed and c an mak e tr e atment mor e challenging.
Bone Ischemia :  R educed blood flo w t o the bone . This is a major f act or in the  
de v elopment of ost eom y elitis, as it compr omises the bone 's abilit y t o fight  
inf ection.
🩸  H e m a t o g e n o u s  v s .  N o n - H e m a t o g e n o u s  
O s t e o m y e l i t i s
This classific ation is b ased on the r out e of inf ection:
Hemat ogenous Ost eom y elitis :  Bact er ia r each the bone via the bloodstr eam .  
This is mor e common in childr en and c an af f ect mul tiple sit es.
Ost eom y elitis
1Common p at hogens :  St aph y lococcus aur eus  (including  
MRSA,  Pseudomonas aeruginosa ,  Ser r atia mar cescens (in IV drug  
users),  Asper gillus  (immunocompr omised),  Bet a-hemol y tic  
str ept ococci ,  M y cobact er ium tuber culosis ,  Candida  species.
Risk f act ors  Age 50 ( childr en), IV drug use, endoc ar ditis, indw elling  
v ascular de vices, or thopedic har dwar e, hemodial ysis, sickle cell dise ase.
Non-Hemat ogenous Ost eom y elitis :  Inf ection spr eads dir ectl y t o the bone fr om  
adjacent tissues . This is mor e common in adul t s and of t en associat ed with  
trauma or sur ger y .
Common p at hogens :  St aph y lococcus aur eus  (including MRSA,  
co agulase-negativ e st aph y lococci, aer obic gram-negativ e  
b acilli,  Cor ynebact er ia , fungi, and m y cob act er ia.
Risk f act ors  P oor l y he aling w ounds ( diabetic f oot ulcers, decubitus ulcers),
or thopedic har dwar e, diabet es, per ipheral v ascular dise ase, per ipheral  
neur op ath y .
🔬  M i c r o b i o l o g y  a n d  D i a g n o s t i c s
Cul tur e and Sensitivit y :  Essential f or guiding antibiotic ther ap y . Ide all y , this  
should be per f or med on a bone biopsy sample, as cul tur es fr om other sour ces  
(swabs, sinus tract s) ar e pr one t o cont amination and f alse-negativ e r esul t s.
Blood Cul tur es :  Ma y be positiv e in hemat ogenous ost eom y elitis , but c an be  
negativ e if b act er emia has r esol v ed b y the time of diagnosis.
Imaging :
A cut e 2 w eeks)  CT or MRI ar e pr ef er r ed f or e ar l y det ection.
Chr onic 2 w eeks)  X -ra ys ma y suf fice initiall y , but MRI is of t en needed  
f or complet e assessment.
Diabetic f oot inf ections  MRI is of t en the imaging modalit y of choice.
Met al har dw ar e  Nucle ar imaging ( e.g., bone sc an) ma y be necessar y .
Labor at or y Findings  Ele v at ed whit e blood cell count WBC, er y thr oc y t e  
sediment ation rat e ESR, and C-r e activ e pr ot ein CRP ar e common, but not  
alwa ys pr esent, especiall y in chr onic c ases.
💊  T r e a t m e n t  S t r a t e g i e s
Ost eom y elitis
2Antibiotic Ther ap y  The cor nerst one of ost eom y elitis tr e atment. Duration  
v ar ies gr e atl y depending on the t ype of ost eom y elitis, pr esence of sequestra,  
and r esponse t o tr e atment.
Non-hemat ogenous  Of t en r equir es pr olonged IV or highl y bio a v ailable oral  
antibiotics 6 w eeks). Sur gic al debr idement (r emo v al of inf ect ed tissue ) is  
fr equentl y necessar y .
Hemat ogenous  Duration is less cer t ain, but generall y 4 w eeks without  
sur gic al debr idement, and longer with sur gic al int er v ention.
Sur gic al Debr idement :  R emo v al of inf ect ed bone and tissue . Essential f or  
chr onic ost eom y elitis and c ases with signific ant bone destruction or sequestra.
Har dw ar e R emo v al  Ma y be necessar y in c ases of inf ection in v ol ving  
or thopedic implant s. This of t en r equir es a shor t er course of antibiotics post -
sur ger y .
🦴  S p e c i f i c  F o r m s  o f  O s t e o m y e l i t i s
V er t ebr al Ost eom y elitis Spond y lodiscitis) :  Inf ection of the v er t ebr ae and  
int er v er t ebr al discs . Of t en pr esent s with b ack p ain, pot entiall y le ading t o spinal  
def or mities and neur ologic al complic ations.  St aph y lococcus aur eus  is the most  
common p athogen.
St er nocla vicular and P el vic Ost eom y elitis  Mor e common in IV drug users due  
t o the r isk of b act er emia.
Long Bone Ost eom y elitis  Mor e common in childr en.
👣  D i a b e t i c  F o o t  I n f e c t i o n s  a n d  O s t e o m y e l i t i s
Diabetic F oot Inf ections  A signific ant complic ation of diabet es, of t en le ading  
t o ost eom y elitis. Neur op ath y , per ipheral v ascular dise ase, and imp air ed  
immune function incr e ase the r isk.
Risk F act ors  Pr e vious f oot ulceration, neur op ath y , f oot def or mit y , v ascular  
dise ase, cer t ain medic ations ( e.g., SGL T2 inhibit ors), age, ethnicit y ,  
socioeconomic st atus.
Management  Includes thor ough assessment, shar p debr idement, w ound c ar e,  
pr essur e r eduction ( of flo ading), and pr e v ention of r elapses. Antibiotic therap y  
is crucial, guided b y cul tur e and sensitivit y r esul t s. The duration of antibiotic  
Ost eom y elitis
3therap y is t ailor ed t o the se v er it y of the inf ection and the pr esence of  
ost eom y elitis.
I m p o r t a n t  F a c t s  t o  M e m o r i z e
 Ost eom y elitis def inition and classif ic ation (acut e vs.  chr onic,  
hemat ogenous vs.  non-hemat ogenous).
 K e y p at hogens f or e ach t ype of ost eom y elitis.
 Risk f act ors f or hemat ogenous and non-hemat ogenous ost eom y elitis.
 Clinic al pr esent ation of ost eom y elitis (acut e vs.  chr onic ).
 Diagnostic modalities ( blood cul tur es,  imaging,  bone biopsy).
 Impor t ance of bone biopsy f or cul tur e and sensitivit y .
 Pr inciples of antibiotic t her ap y ( dur ation,  r out e of administr ation).
 R ole of sur gic al debr idement and har dw ar e r emo v al.
 Specif ic f or ms of ost eom y elitis (v er t ebr al,  st er nocla vicular ,  pel vic,  long  
bone ).
 Diabetic f oot inf ections: r isk f act ors and management.
 The signif ic ance of neur op at h y and v ascular dise ase in diabetic f oot  
inf ections.
 P at hogenesis of ost eom y elitis (ischemia,  sequestr a f or mation,  sinus tr act
f or mation).
 In v olucrum and clo ac ae: t heir signif ic ance in chr onic ost eom y elitis.
 Common complic ations of ost eom y elitis (abscess f or mation,  
neur ologic al def icit s).
 The impor t ance of e ar l y diagnosis and tr e atment in pr e v enting  
complic ations.
 Int er pr eting labor at or y f indings WBC,  ESR,  CRP.
 Underst anding t he limit ations of non-bone tissue cul tur es in diagnosing  
ost eom y elitis.
 The r ole of imaging in guiding tr e atment decisions.
 The challenges in tr e ating chr onic ost eom y elitis.
Ost eom y elitis
4 The incr e ased mor t alit y r isk associat ed wit h diabetic f oot inf ections.
C o m p a r i s o n  T a b l e :  H e m a t o g e n o u s  v s .  N o n -
H e m a t o g e n o u s  O s t e o m y e l i t i s
F e atur e Hemat ogenous Ost eom y elitis Non-Hemat ogenous Ost eom y elitis  R out e  
of Inf ection  Bloodstr e am Dir ect spr e ad fr om adjacent tissues  A ge Gr oup  Mor e  
common in childr en, v er t ebral in adul t s Mor e common in adul t s  Onset  Of t en  
acut e Can be acut e or chr onic  P at hogens   S. aur eus ,  P . aeruginosa ,  S.  
mar cescens , et c.  S. aur eus , co agulase-negativ e st aph y lococci, et c.  Risk  
F act ors  IV drug use, endoc ar ditis, indw elling de vices, et c. P oor l y he aling  
w ounds, diabet es, v ascular dise ase, et c.  T r e atment  Antibiotics, sometimes  
sur ger y Antibiotics, of t en sur ger y ( debr idement, har dwar e r emo v al)
This stud y guide pr o vides a frame w or k f or y our oral e xam pr ep aration.  
R emember t o e xp and on these point s and practice e xplaining the concept s in  
y our o wn w or ds. Good luck!
Ost eom y elitis
5